Aetrex Partners with The Charcot-Marie-Tooth Association, a national non-profit devoted to Charcot-Marie-Tooth (CMT) disorder, announced a partnership with Aetrex Worldwide, Inc., the maker of comfort and wellness footwear products. The partnership will focus on two critical areas: the delivery of comfortable, well-designed shoe solutions to people with CMT while creating awareness about CMT and the CMTA to the public and the trade through Aetrex’s broad reach of customers and professionals.
“The footwear options provided by Aetrex are a natural fit for those with CMT,” said Pat Livney, CEO of the Charcot-Marie-Tooth Association. “The multiple shoe lines offered by Aetrex provide numerous solutions for those who usually have difficulty finding a comfortable and stylish shoe. The CMTA is grateful to provide opportunities to improve the quality of life for CMT patients across the country. This partnership will definitely fill the basic need of quality, well-fitted shoes.”
An estimated one in every 2,500 people 2.6 million worldwide has CMT. It is a progressive disorder that causes the nerve cells leading to the body’s extremities to slowly degenerate, resulting in the loss of normal use of the hands/arms and legs/feet. It may also lead to a loss of sensory functions and structural changes in the feet and hands, which can lead to difficulties finding shoes that fit correctly. CMT affects people of all ages, genders, races and ethnicities, yet sometimes is overlooked and not routinely diagnosed in patients.
“We’re very excited to partner with the CMTA,” said Larry
Schwartz, CEO of Aetrex. “Their vision of seeing a world without CMT is
something we hope to help them accomplish.”
Founded in 1946, Aetrex Worldwide, Inc. is widely recognized as the global leader in pedorthic footwear and foot orthotics.
